InsidersTradesSigma
Track the Bicara Therapeutics Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €1.6bn. The latest transaction was reported on 12 August 2026 (Levée d'options). Among the most active insiders: Cohlhepp Ryan. Every trade is accessible without an account.
82
Insider Decl.
n/a
Thresholds
€4m
1 ops.
Buy Volume
€4m
20 ops.
Sell Volume
47Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 August 2026
Declarations82 total
18,750 shares@ US$3.7898Common StockSEC:0001470831-26-000812:0
18,750 shares@ US$27.9751Common StockSEC:0001470831-26-000812:1
10,000 shares@ US$3.7898Common StockSEC:0001470831-26-000813:0
10,000 shares@ US$27.975Common StockSEC:0001470831-26-000813:1
10,000 shares@ US$27.830.015% mcap13.7% of flowCommonSEC144:0001969223-26-000869
18,750 shares@ US$27.830.028% mcap16.9% of flowCommonSEC144:0001969223-26-000872
10,000 shares@ US$3.78980.0020% mcap2.2% of flowCommon StockSEC:0001470831-26-000714:0
9,972 shares@ US$28.41630.015% mcap16.3% of flowCommon StockSEC:0001470831-26-000714:1
28 shares@ US$29.680.0000% mcap0.0% of flowCommon StockSEC:0001470831-26-000714:2
10,000 shares@ US$29.680.016% mcap21.0% of flowCommonSEC144:0001969223-26-000775
18,750 shares@ US$3.78980.0038% mcap2.8% of flowCommon StockSEC:0001470831-26-000701:0
22,833 shares@ US$28.75890.035% mcap26.0% of flowCommon StockSEC:0001470831-26-000701:1
4,306 shares@ US$29.79610.0068% mcap5.1% of flowCommon StockSEC:0001470831-26-000701:2
1,075 shares@ US$30.35490.0017% mcap1.3% of flowCommon StockSEC:0001470831-26-000701:3
536 shares@ US$29.000.0008% mcap0.6% of flowCommon StockSEC:0001470831-26-000701:4
50,000 shares@ US$28.56160.075% mcap100.0% of flowCommonSEC144:0001950047-26-006962
28,750 shares@ US$30.250.046% mcap73.7% of flowCommonSEC144:0001969223-26-000773
25 of 82 declarations
About Bicara Therapeutics Inc.
Bicara Therapeutics Inc. is a biopharmaceutical company focused on developing innovative therapies for cancer treatment. It employs immunotherapy-based approaches to target tumors.